Comparison of the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphineinduced pruritus
Cruz Ferretti, Ulises y Llanes Garza, Hilda Alicia y López Cabrera, Norma Guadalupe y Espinosa Galindo, Ana María y Palacios Ríos, Dionicio y Cano García, Martha Araceli y Estrada Solís, Yesenia Nohemí (2014) Comparison of the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphineinduced pruritus. Medicina universitaria, 16 (64). pp. 107-111. ISSN 1665-5796
|
Texto
X1665579614675853_S300_en.pdf - Versión Publicada Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (196kB) | Vista previa |
Resumen
Objective: To compare the eficacy and safety of 4 mg of ondansetron vs. 4 mg of nalbuphine for the treatment of neuraxial morphine-induced pruritus, in patients at the “Dr. José Eleuterio González” University Hospital from September 2012 to August 2013. Material and methods: A controlled, prospective, randomized study of 28 patients (14 per group) receiving neuraxial morphine analgesia was conducted, which was registered and approved by the ethics Committee of the Institution and patients agreed to participate in the study under informed consent. The results were segmented and contrasted (according to drug) by hypothesis testing; the association was determined by X2 with a 95% conidence interval (CI). Results: Pruritus was effectively resolved in both groups and no signiicant difference was found in the rest of the variables. An increase in the visual analogue scale (eVA) was observed at 6 and 12 hours for the ondansetron group, which was statistically signiicant (p≤0.05), however both groups had an eVA of less than 3. Conclusions: When comparing the eficacy and safety of ondansetron 4 mg vs. nalbuphine 4 mg for the treatment of neuraxial morphine induced pruritus, the only signiicant difference found was the mean eVA at 6 and 12 hours, favoring the ondansetron group. However, both groups scored less than 3 on the eVA. Therefore, we consider that both treatments are effective and safe in the treatment of pruritus caused by neuraxial morphine.
Tipo de elemento: | Article | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Palabras claves no controlados: | Pruritus; Ondansetron; Morphine; Nalbuphine; Neuraxial analgesia; Mexico | ||||||||||||||||||||||||
Materias: | R Medicina > R Medicina en General | ||||||||||||||||||||||||
Divisiones: | Medicina | ||||||||||||||||||||||||
Usuario depositante: | Editor Repositorio | ||||||||||||||||||||||||
Creadores: |
|
||||||||||||||||||||||||
Fecha del depósito: | 21 Oct 2016 20:53 | ||||||||||||||||||||||||
Última modificación: | 18 Mayo 2021 17:43 | ||||||||||||||||||||||||
URI: | http://eprints.uanl.mx/id/eprint/11456 |
Actions (login required)
Ver elemento |